Centers for Disease Control and Prevention
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Centers for Disease Control and Prevention sits in the top decile of US sponsors by registered trial count (#202 of 15,742 sponsors by registered trial count).
Centers for Disease Control and Prevention: 139 sponsored US clinical trials, 3 recruiting.
Centers for Disease Control and Prevention sponsors 139 registered US clinical trials on ClinicalTrials.gov, 3 of them currently recruiting, and 131 completed. 18 of these trials are in Phase 3-4 (later-stage) and 62 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is HIV Infections, with 12 trials.
Top-decile sponsor footprint
Centers for Disease Control and Prevention ranks in the top decile of sponsors by registered trial count (#202 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
131 of 134 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (97.8%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
139 total, page 1 of 3
Virologic and Immunologic Characteristics of Severe Mpox in Persons With Advanced HIV
NCT06045923
Assessment of the Safety, Tolerability, and Effectiveness of Rifapentine Given Daily for LTBI
NCT03474029
The National Amyotrophic Lateral Sclerosis Registry
NCT01772602
CDC-9 Inactivated Rotavirus Vaccine (IRV) Microneedle Patch (MNP) in Healthy Adults
NCT06962904
Short-course Regimens for the Treatment of Pulmonary Tuberculosis
NCT05766267
CDC-9 Inactivated Rotavirus Vaccine (IRV) Intramuscular (IM) Phase 1 Clinical Trial in Healthy Adults
NCT06485258
HIV Prevention Among Latina Transgender Women Who Have Sex With Men: Evaluation of a Locally Developed Intervention
NCT03465852
Just-in-time Elastomeric Training and Fit Testing (JET FIT)
NCT03888898
Immunogenicity of Fractional One-fifth and One-half Doses of Yellow Fever Vaccine Compared to Full Dose in Children 9-23 Months Old
NCT03725618
Immunogenicity Trial of Egg- Versus Non-Egg-Based Influenza Vaccines Among HCP
NCT03722589
Bismuth Subsalicylate's Role in the Prevention of Travelers' Diarrhea
NCT03535272
An Evaluation of Traditional Directly Observed Therapy (DOT) and Electronic DOT for TB Treatment
NCT03266003
Cooperative Re-Engagement Controlled Trial (CoRECT)
NCT02693145
Pharmacokinetic and Pharmacodynamic Study of High-Dose Rifapentine and Moxifloxacin for Treatment of Tuberculosis
NCT02563327
TBTC Study 31: Rifapentine-containing Tuberculosis Treatment Shortening Regimens
NCT02410772
Evaluation of Rapid HIV Self-testing Among MSM (eSTAMP)
NCT02067039
Development and Testing of a Clinic-Based Intervention to Increase Dual Protection Against Unintended Pregnancy and Sexually Transmitted Diseases (STDs) Among High Risk Female Teens
NCT02291224
Sustainable Healthcenter Implementation PrEP Pilot Study
NCT02074891
HIV Clinic-Based Intervention to Improve ART Adherence and Prevent HIV Transmission
NCT02044484
National Health and Nutrition Examination Survey 24-hour Urine Collection Feasibility Study, 2013
NCT02723682
Prospective Comparison of the Tuberculin Skin Test and Interferon-Gamma Release Assays in Diagnosing Infection With Mycobacterium Tuberculosis and in Predicting Progression to Tuberculosis
NCT01622140
Study 33: Adherence to Latent Tuberculosis Infection Treatment 3HP SAT Versus 3HP DOT
NCT01582711
Dating Matters: Strategies to Promote Healthy Teen Relationships
NCT01672541
HIV Prevention Among Latino MSM: Evaluation of a Locally Developed Intervention
NCT01626898
Study of In-home Tests for Colorectal Cancer
NCT01998009
Intervention to Retain HIV-positive Patients in Medical Care
NCT01537367
Evaluation of an Intervention to Increase Colorectal Cancer Screening in Primary Care Clinics
NCT00737646
Serologic Assays for the Diagnosis of Herpes Simplex Virus Type 2
NCT01112956
Study of Intradermal Administration of PCEC Rabies Vaccine
NCT01044199
TBTC Study 29: Rifapentine During Intensive Phase Tuberculosis (TB) Treatment
NCT00694629
A Network Intervention for Reducing Sexual Risk for HIV With African American Men Who Have Sex With Men (AA MSM)
NCT00691041
Project ICARE: Intervening for Community Awareness, Respect, & Empowerment
NCT00712088
Proyecto SOL: A Risk Reduction Intervention for Hispanic Men Who Have Sex With Men (MSM)
NCT00690976
No Excuses/Sin Buscar Excusas Intervention to Reduce Latino Men's HIV Risks
NCT00690690
A Behavioral Intervention to Reduce Sexual Risk Among African-American Men Who Have Sex With Men
NCT00691496
Randomized Controlled Trial of Routine Screening for IPV
NCT00526994
A Computer-based Intervention to Augment Home Visitation Services: The E-Parenting Project
NCT01304719
Evaluation of Walk With Ease in Arthritis
NCT00526435
Preventing Child Maltreatment Through A Cellular-Phone Technology-Based Parenting Program
NCT01294475
Botswana TDF/FTC Oral HIV Prophylaxis Trial
NCT00448669
REDucing Influenza Among University Students, University of California at Berkeley
NCT00448773
Using Technology to Augment the Implementation and Effectiveness of PCIT
NCT01294488
Stopping Upper Respiratory Infections and Flu in the Family: The Stuffy Trial
NCT00448981
Adopting and Demonstrating the Adaptation of Prevention Techniques: Community PROMISE PLUS
NCT00267436
Health Impact Study of Aquatabs in Tamale, Ghana
NCT00252928
Evaluation of the Healthy Love Workshop, an HIV Prevention Intervention for African American Women
NCT00362375
TBTC Study 28: Moxifloxacin Versus Isoniazid for TB Treatment
NCT00144417
Fitness and Exercise for People With Arthritis
NCT00252070
Adopting and Demonstrating the Adaptation of Prevention Techniques (ADAPT), Harlem United Community AIDS Center
NCT00267410
Promoting Colorectal Cancer Screening in Rural Colorado
NCT00137592
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 26 |
| Phase 2 | 36 |
| Phase 3 | 9 |
| Phase 4 | 9 |
Therapeutic Areas
What is open in the Centers for Disease Control and Prevention pipeline
3 recruiting of 139 indexed (2% open); 131 completed (94%).
Phase mix: 18 late (III/IV) vs 62 early (I/II) (early-phase heavy).
Top condition: HIV Infections (12 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Centers for Disease Control and Prevention: open-pipeline peers nationwide
Peers matched on 139 registered trials and 2% open enrollment, not the therapeutic-area sidebar.
Centers for Disease Control and Prevention sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 139 trials (± recruiting share)
- Barbara Ann Karmanos Cancer Institute · 139 trials · 12% recruiting
- Mclean Hospital · 140 trials · 19% recruiting
- Shirley Ryan AbilityLab · 138 trials · 26% recruiting
- Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University · 138 trials · 3% recruiting
Sponsors near 2% open enrollment (± trial volume)
- Baxter Healthcare Corporation · 2% recruiting · 46 trials
- USDA, Western Human Nutrition Research Center · 2% recruiting · 47 trials
- Sun Pharmaceutical Industries · 2% recruiting · 48 trials
- NSABP Foundation · 2% recruiting · 44 trials
Related
What to do with this Centers for Disease Control and Prevention page
139 registered trials is a research-attention snapshot, not an endorsement of Centers for Disease Control and Prevention or any single study.
- 3 of Centers for Disease Control and Prevention's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- HIV Infections is the condition Centers for Disease Control and Prevention studies most, compare against other sponsors active in the same condition before evaluating a specific study. See HIV Infections trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Centers for Disease Control and Prevention pipeline card: 139 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.